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Abstract A retrospective study was carried out in a Hong Kong regional hospital with 24-h emergency service, to
study the factors associatedwith shorter time to re-admission after acute exacerbation of chronic obstructive pulmonary
disease (COPD).From1January1997 to 31December1997, the ¢rst admission (index admission) of each patientthrough
the emergencyroomwith COPD/chronic bronchitis/emphysemawas included. Atotal of 551patients ful¢lled the inclu-
sion criteria.The total acute and rehabilitative length of stay (mean+ SD) was 9?41+11?67 days.Within1year after dis-
charge, 327 patients (59?35%) were re-admitted at leastonce.Mediantime to ¢rst re-admission afterdischargewas 240
days.By Coxregression analysis, the following factorswere independentlyassociatedwith shorter timeto re-admission:
hospital admissionwithin1year before index admission, total length of stay in index admission45 days, nursing home
residency, dependency in self-care activities, right heart strain pattern on electrocardiogram, on high dose inhaled cor-
ticosteroidandactualbicarbonatelevel425mmoll71. These factorsmayberelevantinthe futureplanningof healthcare
utilization for COPD patients.c 2001Harcourt Publishers Ltd
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Chronic obstructive pulmonary disease (COPD) is de-
¢ned as a disease state characterized by the presence of
air£ow obstruction due to chronic bronchitis or emphy-
sema (1). It is a chronic debilitating illnesswhich gives rise
to signi¢cantmorbidity and frequenthospital admissions.
In the United States, the overall prevalence of COPD in
the adult white population is 4^6% in men and 1^3% in
women. In persons older than 55 years,COPD is recog-
nized in approximately 10^15% (2,3). In Hong Kong, a
1991^1992 survey of the prevalence of respiratory symp-
toms and diseases was performed in 2032 (999 males)
elderly (70 years) Chinese by interviews and question-
naires.Chronic bronchitis and emphysemawere found to
be present in 6?85% and 2?4% of subjects respectively
(4). In 1996, COPD ranked ¢rst in the list of dischargeReceived 8 January 2001and accepted in revised form 28 June 2001
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drcwlau@dnamail.comdiagnoses from themedical units of11Hong Kong Hospi-
tal Authority hospitals o¡ering emergencyroom service.
Because COPD is so common, studies on the pattern
of hospital utilization may be useful to assist health ser-
vice planning. In the following study, we aimed to identify
factors associated with shorter time to ¢rst re-admis-
sion after discharge from hospital following treatment
of an acute exacerbation.Wehypothesized that such fac-
tors could be readily obtained at the time of a patient’s
admission.
METHODS
A retrospective study of COPD admissions to themedi-
cal unit of Pamela Youde Nethersole Eastern Hospital
(PYNEH), Hong Kong, through the emergency room for
acute COPD exacerbation from 1 January 1997 to 31
December 1997 was performed using patient chart ab-
straction. PYNEH served a population of 600 000 at the
time of the study and is one of the three regional hospi-
tals in Hong Kong Island o¡ering 24-h emergency room
service.The ¢rst hospitalization for COPD exacerbation
of each patient within the study period, de¢ned as the
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Hong Kong Hospital Authority from its territory-wide
computer database using the International Classi¢cation
of Diseases 9th Revision Clinical Modi¢cation (ICD-9-
CM) coding.The database also tracked all admission epi-
sodes before and after the index admission if the study
patients were admitted to any hospital under the Hong
KongHospitalAuthority,which serves about 93%ofhos-
pitalized patients in Hong Kong. The following codes as
the primary or secondary discharge diagnosis were iden-
ti¢ed: 491?21 (obstructive chronic bronchitis with acute
exacerbation), 492 (emphysema) and 496 (chronic airway
obstruction, not classi¢ed elsewhere). Patients were
included if (a) their primary discharge diagnoses were
one of the above codes or if (b) the primary discharge
diagnoses were 480 (viral pneumonia), 481 (pneumococ-
cal pneumonia), 482 (other bacterial pneumonia), 483
(pneumonia due to other speci¢ed organism), 485
(bronchopneumonia), 486 (pneumonia, organism unspe-
ci¢ed); and the secondary diagnoses were 491?21, 492 or
496. These criteria should include most patients with
COPD exacerbations due to chest infection, pneumonia,
or other unspeci¢ed causes. Exclusion criteria were: (a)
exacerbations due to pneumothorax, (b) co-existing pul-
monary diseases which may predict early re-admission
(asthma, bronchiectasis, restrictive lung diseases includ-
ing signi¢cant ¢brosis or destroyed lung due to old pul-
monary tuberculosis, kyphosis, interstitial lung disease),
(c) lung cancer diagnosed within 3 months before the in-
dex admission or currently on chemotherapy, (d) pul-
monary tuberculosis on treatment, and (e) death in
index admission. Past and subsequent admissions were
also subject to the same inclusion and exclusion criteria.
Doctors in the emergency room and medical wards
were not aware of this study.
Data collection was performed by two authors
(A.C.W.L., E.P.). Information on the index admission was
obtained from notes by physicians, nurses, physiothera-
pists, occupational therapists and social workers. In par-
ticular, the admission ‘nursing cardex’, which contained
detailed information on smoking status and history,
occupation, marital status, home care and welfare sup-
port status, self-care abilities, and use of long term oxy-
gen therapy, was an important and reliable source of
data. Variables analysed included (a) demographic data
(age, sex, number of admissions before and after index
admission, dates of index admission and discharge, acute
and rehabilitative lengths of stay in index admission, date
of ¢rst re-admission after discharge from index admis-
sion), (b) social data (smoking status, occupation, marital
status, home care and social welfare status, self-care
ability in activities of daily living), (c) lung function data
(best peak expiratory £ow rate in index admission), (d)
non-pulmonary co-morbidities [presence of chronic at-
rial ¢brillation or multifocal atrial tachycardia, right
heart strain pattern on electrocardiogram (EKG), dia-betes mellitus, coronary artery disease, left ventricular
failure], (e) results of ¢rst blood test in index admission
(haemoglobin, total white blood cell count, creatinine,
albumin, pH, PCO2, actual bicarbonate), (f) past treat-
ment (long-term oxygen therapy, high dose inhaled or
systemic corticosteroid). Baseline PaO2 values were not
analysed because many of these patients had already
been given oxygen supplement before blood gases were
checked.
De¢nitions of selectedvariables are as follows: depen-
dence or requirement of assistance in activities of daily
living = dependent/required assistance in at least one of
the following activities: mouth-washing, bathing, feed-
ing, grooming, toileting, walking; presence of right heart
strain on EKG = EKG evidence of p pulmonale (p wave
axis 908), right bundle branch block or absent or mar-
ginal increase of R wave amplitude from V1 to V6 leads.
Treatment with high dose inhaled corticosteroid =
1000mg beclomethasone-equivalent per day for 3
months before the date of index admission. Treatment
with high dose systemic corticosteroid =  15mg pred-
nisolone-equivalent per day for  3 months before the
date of index admission. Cut-o¡ points to de¢ne long-
term high dose inhaled and systemic corticosteroids are
arbitrary, however, they represent the dosages above
which signi¢cant side-e¡ectsmight occur.
Statistical analysis
Relationship between patient characteristics and time to
¢rst re-admission was analysed by Kaplan^Meier analy-
sis. Absence of re-admissionwithin1year after discharge
from the index admission was taken as censored status.
Independent factors associated with shorter time to
¢rst re-admission after discharge were identi¢ed by in-
corporating those factors with log-rank test P-values
50?05 into a Cox proportional hazards regressionmod-
el using forward step-wise entry. Statistical analysis was
carried out using SPSS1 version 9.
RESULTS
In 1997, 760 patients admitted for COPD exacerbation
into themedicalunitof PYNEHwere identi¢ed. Informa-
tion was incomplete in 27 patients and they were ex-
cluded. Another 182 patients did not ful¢ll the inclusion
criteria: exacerbations due to pneumothorax (six
patients), one or more co-existing pulmonary diseases
as listed [142 patients: asthma (85), restrictive lung
diseases (29), bronchiectasis (28)], lung cancer (10
patients), active pulmonary tuberculosis (¢ve patients)
and death in index admission (19 patients). Demographic
and characteristics of the 551 patients included in the
¢nal analysis are shown inTable1.Themajorityofpatients
were unemployed/retiredmales with a smoking history.
TABLE 1. Demographic and clinical characteristics of 551COPD patients
Variable Mean+standard deviation
(% totalnumberof patients)
Demographic data and lung function
Age 73?75+8?59
(median 75, range 45^100)
Male sex 426 (77?3%)
Smoking status
Non-smoker 20 (3?6%)
Ex-smoker 384 (69?7%)
Active smoker 147 (26?7%)
Occupation
Professional 1 (0?2%)
Skilled 12 (2?2%)
Unskilled/semi-skilled 22 (4?0%)
Unemployed/retired 516 (93?6%)
Best peakexpiratory £owrate (lmin71)
5 100 79 (14?3%)
100 ^ 200 254 (46?1%)
4200 113 (20?5%)
Notdone 105 (19?1%)
Totallength of stay (days) 9?41+11?67 (median 5, range 0^104)
Acute 4?05+4?16 (median 3, range 0^34)
Rehabilitative 5?36+10?64 (median 0, range 0^103)
Results of ¢rst blood test after admission
Haemoglobin (gdl71) 12?89+1?78
Totalwhite blood cell count (x109ml71) 9?58+4?22
Creatinine (mml71) 89?00+33?59
Albumin (gl71) 39?03+4?60
pH 7?38+0?06
PaCO2 (mmHg) 44?72+12?71
Actualbicarbonate (mmoll71) 25?74+5?01
FIG. 1. Kaplan^Meier plot of time to ¢rst re-admission within 1
year afterdischarge fromindex admission (n= 551).
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from the index admissions, 327 (59?35%) patients
had been re-admitted at least once.The median time to
¢rst re-admissionwas 240 days [95% con¢dence interval
(CI) 204^276 days, Fig. 1]. The relationship between
patient characteristics and time to ¢rst readmissionwas
analysed by Kaplan^Meier analysis and is shown in
Table 2. The following factors were associated with
shorter time to ¢rst re-admission after discharge from
index admission: age 475 years, hospital admission
within 1 year before index admission, length of stay in
index admission 45 days, nursing home residency,
dependency/requirement for assistance in self-care
activities, right heart strain pattern on EKG, coronary
artery disease, left ventricular failure, on long-term
oxygen therapy, on high dose inhaled corticosteroid, on
high dose systemic corticosteroid, PaCO2 450mmHg
and actual bicarbonate level 425mmol l71.
Figure 2(a)^(d) is bar-charts showing the mean + SEM
of the percentage of patients not yet re-admitted
within 1 year after discharge from index admission
with respect to their demographic and social data
[Fig. 2(a)], co-morbidities [Fig. 2(b)], treatmentcategories [Fig. 2(c)] and ¢rst blood investigation after
admission [Fig 2(d)].
For Cox regression analysis, two models were set up
because 54 patients did not have blood test results for
TABLE 2. Kaplan^Meier analysis of time to ¢rst re-admissionwithin1year afterdischarge fromindex admission
Predictive variable Subgroups Numberof
patients
% of patients not yet
re-admitted
P-value*
Demographic and social data
Age, years 75
475
299
252
47?49+2?89
32?54+2?95
0?0013
Sex M
F
426
125
41?08+2?38
39?20+4?37
0?5778
Hospital admission inprevious year Yes
No
194
357
27?32+3?20
47?9+2?64
50?0001
Totallength of stay in index admission, day(s) 5
45
286
265
45?1+2?94
35?85+2?95
0?0100
Discharged fromrehabilitationbed Yes
No
259
292
44?4+3?09
37?33+2?83
0?2679
Marital status Marriedwith
spouse alive
Single/widowed/
divorced/separated
376
175
42?29+2?55
37?14+3?65
0?1537
On socialwelfare Yes
No
171
380
37?43+3?70
42?11+2?53
0?2033
Nursinghomeresidents Yes
No
46
505
23?91+6?29
42?18+2?20
0?0002
Self-care ability Dependent/required
assistance
Independent
116
435
26?72+4?11
44?37+2?38
50?0001
Comorbidities
Chronic atrial ¢brillation ormultifocal
atrial tachycardia
Yes
No
17
534
29?41+11?05
41?01+2?13
0?2489
Rightheart strainpattern on EKG Yes
No
121
430
28?10+4?09
44?19+2?39
0?0001
Diabetesmellitus Yes
No
37
514
37?84+7?97
40?86+2?17
0?9461
Coronary arterydisease Yes
No
46
505
15?22+5?36
42?97+2?20
0?0008
Left ventricular failure Yes
No
28
523
21?43+7?75
41?68+2?16
0?0216
Treatment
Mechanical ventilation Yes
No
16
535
31?25+11?59
40?93+2?13
0?1357
Non-invasive ventilation only Yes
No
9
542
22?22+13?86
40?96+2?11
0?2435
Onlong-termoxygentherapy Yes
No
46
505
15?22+5?30
42?97+2?20
50?0001
Onhigh dose inhaled corticosteroid Yes
No
96
455
25?00+4?42
43?96+2?33
0?0003
Onhigh dose systemic corticosteroid Yes
No
13
538
15?38+10?01
41?26+2?12
0?0151
First blood investigation after admission
Haemoglobin, (gdl71) 15
415
Not available
465
54
32
40?86+2?28
37?04+6?57
0?7386
Total WBCcount (x109ml71) 10
410
Not available
338
181
32
40?83+2?67
39?78+3?64
0?6988
Creatinine (mml71) 130
4130
Not available
474
48
29
40?51+2?25
43?75+7?16
0?7520
Albumin (gl71)  35
435
Not available
99
381
71
42?42+4?97
39?63+2?51
0?9801
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pH 7?35
47?35
Not available
131
366
54
41?22+4?30
41?26+2?57
0?8105
PaCO2 (mmHg) 50
450
Not available
382
115
54
44?24+2?54
31?30+4?32
0?0073
Actualbicarbonate (mmoll71) 25
4 25
Not available
243
254
54
49?79+3?21
33?07+2?95
0?0004
*Log-rank test.
TABLE 2. (continued)
Predictive variable Subgroups Numberof
patients
% of patients not yet
readmitted
P-value*
FIG. 2. Bar-charts showing themean+SEMofthepercentage ofpatientsnot yetre-admittedwithin1year afterdischarge fromindex
admission with respect to demographic and social data (a), co-morbidities (b), treatment categories (c) and ¢rst blood investigation
after admission (d).
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TABLE 3. Cox proportional hazards analysis of independent factors associatedwith shorter time to ¢rst re-admission [model1:
onlypatientswith blood test results (n=497); model 2: all patients, blood test results not analysed (n = 551)]
Model1 Model 2
Condition Hazards ratio P-value Hazardsratio P-value
(95% CI) (95% CI)
Hospital admission inprevious1year 1?553 5 0?001 1?509 5 0?001
(1?219^1?977) (1?200^1?898)
Totallength of stay in index admission4 5 days 1?403 0?004 1?274 0?030
(1?111^1?771) (1?023^1?586)
Nursinghomeresidency 1?718 0?006 1?679 0?006
(1?169^2?525) (1?163^2?424)
Dependencyin self-care activities 1?396 0?017 1?498 0?002
(1?062^1?835) (1?157^1?940)
Rightheart strainpattern on EKG 1?557 0?001 1?602 5 0?001
(1?188^2?039) (1?248^2?056)
Onhigh dose inhaled corticosteroid 1?354 0?036 1?374 0?021
(1?020^1?799) (1?049^1?799)
Actualbicarbonate4 25 mmoll71 1?351 0?014
(1?062^1?720)
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those patients with blood results (n=497) and the sec-
ond one included all patients (n=551) but excludedblood
results in the analysis. For model 1, the following were
independent factors for shorter time to re-admission:
hospital admission within 1 year before index admission,
length of stay in index admission45 days, nursing home
residency, dependency in self-care activities, right heart
strain pattern on EKG, on high dose inhaled corticoster-
oid, and actual bicarbonate level 425mmoll71. For
model 2, similar factors apart from actual bicarbonate
level 425mmol l71 are found. Kaplan^Meier plots of
these independent factors are shown in Fig. 3(a)^(g).
DISCUSSION
This study con¢rmed that re-admissions after acute
COPD exacerbation were common, and that factors
readily obtainable fromhistory taking and simple investi-
gations at the time of admissionwererelated to timingof
subsequent re-admissions.
The retrospective nature of this study has the advan-
tage that the decision to admit or discharge was not
biased by the study and the results therefore can be
taken to represent the real-life situation in our hospital.
However, we believe that several major factors notööööööööööööööööööööööööö
FIG. 3. Kaplan^Meier plots of the independent factors associated
bicarbonate levelwhere n= 497).The log-rank testwasused forco
(b) length of stay in index admission (P50?0100), (c) nursing hom
(P50?0001), (e) rightheart strainpatternon EKG (P50?0001), (f) on
nate level inmmoll71 (P50?0004).assessed by this study could in£uence its results, includ-
ing the insurance system (which does not play a signi¢-
cant role in hospital care ¢nancing locally because 93?1%
of the territory’s inpatients are under the care of hospi-
tals under government-funded Hospital Authority), so-
cio-economical factors, physicians’ subjective opinions
and patients’ preferences. Although data from private
hospitals were not available, they are not expected to
have any signi¢cant in£uence on the results of our data,
as only 6?9% of total hospital days were being utilized in
private hospitals (1998 data).
A major drawback in this study is the lack of pulmon-
ary function data as an assessment of severity. The role
of forced expiratory volume in 1sec (FEV1) in predicting
hospital utilization is controversial (5^7). Most previous
studies on COPD hospitalization did not, however, pro-
vide comprehensive information or analysis in lung func-
tion. Even in a well-designed prospective study like
SUPPORT (8), only 27% of patients had pulmonary func-
tion tests performed within 1 year of admission. In our
study, 19?1% did not have peak expiratory £ow rate per-
formedduring their inpatient stay. Apart fromaresearch
setting, lung function testing may not be practical for
various reasons in patients admitted for exacerbations,
which may include problems with the ability of a sick
patient to perform the maneuvre, technique of the
patients, timing of performance in relation to theööööööööööööööööööööööö"
with shorter time to ¢rst re-admission (n = 551except in actual
mparison. (a) Hospitalre-admissioninprevious1year (P50?0001),
e residency (P50?0002), (d) dependency in self-care activities
highdoseinhaledcorticosteroids (P50?0003, (g) actual bicarbo-
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ment. However, we believe that lung function testing is
an integral component in COPD management, both to
monitor the trend of exacerbations and to allow severity
categorization. Further limitations of our study include
the diagnostic accuracy of COPD, which depended only
on the attendingphysicians’ judgment, and also, details of
drug treatment and sputumbacteriology were not avail-
able.Only information on corticosteroids was collected
because these drugs are considered to have potentially
signi¢cant side-e¡ects, and there were still controver-
sies regarding their e⁄cacy in COPD at the time of the
study. It is possible thatmedications other than corticos-
teroids, as well as the adequacy of treatment, could also
in£uence the time to re-admission.
We have excluded other respiratory co-morbidities
(asthma, bronchiectasis and restrictive lung diseases) in
the analysis, because in our preliminary analysis inwhich
we included patients with these co-morbidities, they
were found to bevery signi¢cant independentpredictors
of early re-admission in themselves, to the extent that
they overshadowed the signi¢cance of other factors.
Exacerbation of COPD due to other causes such as
pneumothorax and acute decompensated congestive
heart failure were also excluded, because they are in
their own rights distinct reasons for admission indepen-
dent of whether COPD is exacerbated or not, and the
treatment and course of these conditions could often be
easily distinguished from the usual infective or non-infec-
tive cause of COPD exacerbation. On the other hand,
co-existing stable chronic left ventricular failure was
found to be a factor associated with early re-admission
in the study patients on univariate analysis.We believe
that all these co-morbidities are important contributing
factors to COPDmorbidity.
PaO2 and SpO2 levels could vary greatly during the
course of treatment with oxygen or bronchodilators.
At the initial data collection, reliable data on PaO2 and
SpO2 levels could not be obtained because documenta-
tion of the prevailing oxygen level was not complete.We
have therefore decided not to include them in the ¢nal
analysis.
Manyprevious studies have foundhigher total number
of re-admissions or lengths of hospital stay to be related
to various patient factors, including higher (worse)
scores on the St George’s Respiratory Questionnaire
(9,10); more frequent past exacerbations, daily cough,
daily wheeze, bronchitic symptoms (10); reduced quadri-
ceps force andmaximal expiration pressure (7); respira-
tory symptoms (cough, mucus hypersecretion,
breathlessness) and FEV1 (5,11); lower socioeconomic in-
dex, household income and education (12).The only pro-
spective study to assess predictors of the time to ¢rst
hospitalization for exacerbation of COPD was reported
by Kessleret al. (13) in 64 stable outpatients withmoder-
ate to severe COPD. The median time to ¢rst hospitaladmission for acute exacerbation was 29 months (95%
CI 24^33 months) after assessment, which was much
longer than the 240 days in our study of inpatients. By
multivariate analysis,PaCO2 andmean pulmonary arter-
ial pressure (measured with pulmonary artery catheter)
at restwere independent predictive factors of early hos-
pital admission.The results of our study showedpossibly
similar conclusion, with less invasive and indirectmeans,
that high actual bicarbonate level (which re£ects chronic
hypercapnia) and right heart strain pattern on EKG
(which crudely re£ects underlying pulmonary hyperten-
sion complicating COPD in the patients studied) were
two of the independent factors.
Abnormalities of gas exchange have therefore been
found in both Kessler’s and our study to be signi¢cantly
related to shorter time to ¢rst admission and re-admis-
sion. It is possible that early identi¢cation of complica-
tions such as cor pulmonale and its early prevention
with oxygen therapy, which had been proved to improve
survival (14,15), may be important ways to reduce re-ad-
missions. Patients with chronic hypercapnia, and hence
raised actual bicarbonate, are probably more easily
symptomatic than normocapnic patients because of
their rapid and shallow breathing pattern (16), resulting
in earlier and more frequent medical attention seeking.
Indeed, use of domiciliary non-invasive positive pressure
support ventilation in selected patients has been found
to result in improvements in arterial blood gas tensions
(17,18), reduction in both hospital admissions and general
practitioner visits (17), as well as improved quality of life
in chronic hypercapnic COPD patients (18).
In our study, hospital admission in thepast1year, longer
length of stay and use of inhaled corticosteroids, were
also independent factors. These are likely to re£ect the
severity of the underlying COPD. Both inhaled and oral
corticosteroids are signi¢cant factors in univariate analy-
sis, butonly inhaled corticosteroid is retained in themulti-
variate analysis.
Our results showed that nursing home residentswere
re-admitted early. Nursing home care is not well devel-
oped in Hong Kong. Although it is possible that nursing
home residents could be sicker, it is our general feeling
that nursing home sta¡ tend to bring the residents to
seek medical care (especially emergency room atten-
dance) more frequently and earlier even for minor ex-
acerbations, and these residents might therefore also be
admittedmore easily. Some form of outreach team care
such as a respiratory home care service may help to
reduce this type of admission.
Self-care ability re£ects the severity of a patient’s un-
derlying illness, and is a major factor determining quality
of life and self-esteem.Moreover, the stress of the care-
givers may also have a bearing on earlier re-admission
andmay require further investigation.Home-based nur-
sing care programmes are being studied to see if they
can reduce the number of admissions or healthcare
884 RESPIRATORYMEDICINEutilization, but results weremixed (19^24), probably due
to di¡erent study populations and methods of interven-
tion.
In conclusion, information obtained at the time of a
COPD patient’s hospital admission was related to the
time to re-admission in our study. These factors may be
relevant in the future planning of healthcare utilization
for COPD patients. With early identi¢cation of these
factors and aggressive prevention of complications, pa-
tients can be re-categorized into di¡erent levels of care
and rehabilitation needs more rationally. It is hoped that
re-admissions for COPD exacerbation and excessive
consumption of health care resources can thus be
reduced.
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